Table 3

Distribution of rubella IgG antibodies in relation to the clinical information of pregnant women

VariablesDescriptive data
n (%) tested
Rubella seroprevalenceUnivariable logistic regression
IgG-negative, n (%)IgG-positive, n (%)χ2 testOR (95% CI)P value
Fever
 Yes83 (17)13 (16.3)67 (83.8)0.590.7 (0.4 to 1.532)0.486
 No418 (83)54 (13.7)340 (86.3)
Lymphadenopathy
 Yes20 (4)5 (27.8)13 (72.2)0.150.3 (0.1 to 1.1)0.089
 No482 (96)62 (13.6)395 (86.4)
Hepatic signs
 Yes9 (1.8)0 (0)7 (100)0.60
 No493 (98.2)67 (14.3)401 (85.7)
Digestive signs
 Yes165 (33)28 (18.1)127 (81.9)0.090.6 (0.3 to 1.0)0.101
 No337 (67.1)39 (12.2)281 (87.8)
Articular signs
 Yes105 (21)16 (16.5)81 (83.5)0.510.8 (0.4 to 1.5)0.555
 No397 (79.1)51 (13.5)327 (86.5)
Cutaneous signs
 Yes56 (11)9 (17)44 (83)0.530.7 (0.3 to 1.6)0.477
 No445 (89)58 (13.8)363 (86.2)
Cardiac signs
 Yes124 (24.7)14 (11.9)104 (88.1)0.541.3 (0.7 to 2.6)0.337
 No378 (75.3)53 (14.8)304 (85.2)
Respiratory signs
 Yes141 (28)20 (15.3)112 (85)0.70.9 (0.5 to 1.6)0.752
 No361 (82)47 (13.7)296 (86.3)